BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10727981)

  • 1. Up-regulation of pS2 expression during the development of adenocarcinomas but not squamous cell carcinomas of the uterine cervix, independently of expression of c-jun or oestrogen and progesterone receptors.
    Saegusa M; Hashimura M; Hara A; Okayasu I
    J Pathol; 2000 Apr; 190(5):554-63. PubMed ID: 10727981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in expression of estrogen receptors alpha and beta in relation to progesterone receptor and pS2 status in normal and malignant endometrium.
    Saegusa M; Okayasu I
    Jpn J Cancer Res; 2000 May; 91(5):510-8. PubMed ID: 10835496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer.
    Tong D; Schneeberger C; Czerwenka K; Schmutzler RK; Speiser P; Kucera E; Concin N; Kubista E; Leodolter S; Zeillinger R
    Clin Cancer Res; 1999 Jun; 5(6):1497-502. PubMed ID: 10389938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas.
    Shaw JA; Udokang K; Mosquera JM; Chauhan H; Jones JL; Walker RA
    J Pathol; 2002 Dec; 198(4):450-7. PubMed ID: 12434414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas.
    Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Iida K; Nakayama N; Otuski Y; Kobayashi H; Nakayama S; Miyazaki K
    Hum Pathol; 2012 Apr; 43(4):506-19. PubMed ID: 21889186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal trefoil factor (TFF 3) and pS2 (TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium.
    Poulsom R; Hanby AM; Lalani EN; Hauser F; Hoffmann W; Stamp GW
    J Pathol; 1997 Sep; 183(1):30-8. PubMed ID: 9370944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.
    Bièche I; Parfait B; Laurendeau I; Girault I; Vidaud M; Lidereau R
    Oncogene; 2001 Dec; 20(56):8109-15. PubMed ID: 11781824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCC expression is related to mucinous differentiation but not changes in expression of p21(WAF1/Cip1) and p27Kip1, apoptosis, cell proliferation and human papillomavirus infection in uterine cervical adenocarcinomas.
    Saegusa M; Okayasu I
    Br J Cancer; 1999 Apr; 80(1-2):51-8. PubMed ID: 10389977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
    Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
    Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen and progesterone receptor expression in HPV-positive and HPV-negative cervical carcinomas.
    Kwasniewska A; Postawski K; Gozdzicka-Jozefiak A; Kwasniewski W; Grywalska E; Zdunek M; Korobowicz E
    Oncol Rep; 2011 Jul; 26(1):153-60. PubMed ID: 21491087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.
    Daffada AA; Johnston SR; Smith IE; Detre S; King N; Dowsett M
    Cancer Res; 1995 Jan; 55(2):288-93. PubMed ID: 7812959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of oestrogen receptor and oestrogen-inducible genes pS2 and ERD5 in large bowel mucosa and cancer.
    Singh S; Poulsom R; Hanby AM; Rogers LA; Wright NA; Sheppard MC; Langman MJ
    J Pathol; 1998 Feb; 184(2):153-60. PubMed ID: 9602706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of ER, PR, MIB-1, pS2, and nuclear grade in FNA specimens of cT1 breast carcinomas: clinicopathological correlation.
    Angelidou E; Politi E; Sotiropoulou G; Poulianou E; Koutselini H
    Diagn Cytopathol; 2006 Aug; 34(8):547-52. PubMed ID: 16850494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of pS2 messenger RNA in gynecological cancers.
    Wysocki SJ; Hahnel E; Masters A; Smith V; McCartney AJ; Hahnel R
    Cancer Res; 1990 Mar; 50(6):1800-2. PubMed ID: 2306733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pS2 (TFF1) levels in human breast cancer tumor samples: correlation with clinical and histological prognostic markers.
    Gillesby BE; Zacharewski TR
    Breast Cancer Res Treat; 1999 Aug; 56(3):253-65. PubMed ID: 10573116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical investigation and northern blot analysis of c-erB-2 expression in normal, premalignant and malignant tissues of the corpus and cervix uteri.
    Brumm C; Rivière A; Wilckens C; Löning T
    Virchows Arch A Pathol Anat Histopathol; 1990; 417(6):477-84. PubMed ID: 1980167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of pS2 protein in breast cancer and its relationship with estrogen and progesterone receptors].
    Díez Gibert O; Machuca I; Sebastián MA; Rosel P; Navarro MA
    Med Clin (Barc); 1996 Jun; 107(3):90-2. PubMed ID: 8754494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
    Lau KM; LaSpina M; Long J; Ho SM
    Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of oestrogen receptor and oestrogen-inducible genes in pancreatic cancer.
    Singh S; Baker PR; Poulsom R; Wright NA; Sheppard MC; Langman MJ; Neoptolemos JP
    Br J Surg; 1997 Aug; 84(8):1085-9. PubMed ID: 9278646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the pS2 peptide in primary breast carcinomas: comparison of membrane and cytoplasmic staining patterns.
    Dookeran KA; Rye PD; Dearing SJ; Walker RA
    J Pathol; 1993 Oct; 171(2):123-9. PubMed ID: 8283349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.